Mitotic kinesin inhibitors

Details for Australian Patent Application No. 2004311737 (hide)

Owner Merck & Co., Inc.

Inventors Fraley, Mark E.; Arrington, Kenneth L.; Hartman, George D.

Agent Spruson & Ferguson

Pub. Number AU-A-2004311737

PCT Pub. Number WO2005/065183

Priority 60/531,372 19.12.03 US

Filing date 15 December 2004

Wipo publication date 21 July 2005

International Classifications

A61K 31/505 (2006.01) - Pyrimidines

C07D 239/91 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/065183 Priority application(s): WO2005/065183

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp. 2005

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004311743-Systems, methods, and catalysts for producing a crude product

2004311735-Process for making a garment having hanging legs